Catalog |
name |
Description |
price |
R-R-3243 |
PRX-07034 hydrochloride CAS No.903580-39-2 |
PRX-07034 hydrochloride/CAS No.903580-39-2 is a highly selective and potent 5-HT6 receptor antagonist with a Ki= 4-8 nM and an IC50 of 19 nM. PRX-07034 can be used for the research of enhancing working memory and cognitive flexibility. |
price> |
R-R-3244 |
Agomelatine hydrochloride CAS No.1176316-99-6 |
Agomelatine hydrochloride (S-20098 hydrochloride)/CAS No.1176316-99-6 is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively. Agomelatine hydrochloride is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively. |
price> |
R-R-3245 |
5-HT1A modulator 2 hydrochloride CAS No.3880-76-0 |
5-HT1A modulator 2 hydrochloride/CAS No.3880-76-0, a derivative of 8-OH-DPAT (HY-112061), is a modulator of 5-HT1A with a Ki of 53 nM for 5-HT1A binding. |
price> |
R-C-1546 |
WAY-100635 CAS:162760-96-5 |
WAY-100635 was originally believed to act as a selective 5-HT1A receptor antagonist,but subsequent research showed that it also acts as potent full agonist at the D4 receptor. |
price> |
R-R-3246 |
Flumexadol CAS No.30914-89-7 |
Flumexadol/CAS No.30914-89-7 is a selective and affinity 5-HT2C receptor agonist with a Ki of 25 nM for the (+)-enantiomer of Flumexadol, and is 40-fold selective over the 5-HT2A receptor. Flumexadol is an orally active non-narcotic analgesic. |
price> |
R-R-3247 |
Hypidone hydrochloride CAS No.1339058-04-6 |
Hypidone hydrochloride (YL0919)/CAS No.1339058-04-6 is an orally active antidepressant agent with dual activity as a highly seletive 5-HT uptake blocker and an effective 5-HT1A receptor agonist (Ki=0.19 nM). Hypidone hydrochloride inhibits the uptake of [3H]-5-HT into rat cerebral cortical synaptosomes and HEK293 cells with IC50s of 1.78 nM and 1.93 nM, respectively. Hypidone hydrochloride shows remarkable antidepressant effects in animal models and has the poential for the investigation of depressive disorder. |
price> |
R-R-3248 |
Myristicin CAS No.607-91-0 |
Myristicine/CAS No.607-91-0 is an orally bioavailable serotonin receptor antagonist and weak monoamine oxidase (MAO) inhibitor. Myristicine also exerts anti-cancer effects on gastric cancer cells by inhibiting the EGFR/ERK signaling pathway. Myristicine is the main component of nutmeg essential oil and has anti-cancer, anti-proliferative, antibacterial, anti-inflammatory and apoptosis-inducing effects. Myristicine abuse can produce hallucinogenic effects, organ damage, etc. |
price> |
R-R-3249 |
LY266097 hydrochloride CAS No.172895-39-5 |
LY266097 hydrochloride/CAS No.172895-39-5 is a selective 5-HT2B receptor antagonist with pKis of 7.7, 9.8, and 7.6 for 5-HT2A, 5-HT2B, 5-HT2C, respectively. 5-HT2B receptor blockade contributes to the research in depression. |
price> |
R-R-3250 |
Norfluoxetine hydrochloride CAS No.57226-68-3 |
Norfluoxetine hydrochloride/CAS No.57226-68-3 is an active N-demethylated metabolite of Fluoxetine. Fluoxetine is a selective serotonin (5-HT) reuptake inhibitor that is metabolized to Norfluoxetine hydrochloride by cytochrome P450 (CYP) 2D6, CYP2C19, and CYP3A4. Norfluoxetine hydrochloride inhibits 5-HT uptake and inhibits CaV3.3 T current (IC50 = 5 μM). Norfluoxetine hydrochloride has anticonvulsant activity. |
price> |
R-R-3251 |
Didesmethyl cariprazine CAS No.839712-25-3 |
Didesmethyl cariprazine/CAS No.839712-25-3 is a metabolite of Cariprazine and acts as the predominant circulating active moiety. Didesmethyl cariprazine has a long half-life of 1-3 weeks. Cariprazine is a antipsychotic agent candidate that exhibits high affinity for the D3 and D2 receptors, and moderate affinity for the 5-HT1A receptor. |
price> |